EPAS1 and breast carcinoma: To further decipher the relationship between miR-152-3p and EPAS1 and their effects on the progression of breast cancer, we used qRT-PCR, Spearman's correlation, and western blot analyses to show that miR-152-3p may play a negative regulatory role in the expression of EPAS1.